Yu Chun I, Maser Rick, Marches Florentina, Banchereau Jacques, Palucka Karolina
The Jackson Laboratory for Genomic Medicine (JAX-GM), Farmington, CT 06032, USA.
The Jackson Laboratory for Mammalian Genetics (JAX-MG), Bar Harbor, ME 04609, USA.
iScience. 2024 Feb 15;27(3):109238. doi: 10.1016/j.isci.2024.109238. eCollection 2024 Mar 15.
Pre-clinical use of humanized mice transplanted with CD34 hematopoietic stem and progenitor cells (HSPCs) is limited by insufficient engraftment with adult non-mobilized HSPCs. Here, we developed a novel immunodeficient mice based on NOD-SCID- (NSG) mice to support long-term engraftment with human adult HSPCs. As both Flt3L and IL-6 are critical for many aspects of hematopoiesis, we knock-out mouse and knock-in human gene. The resulting mice showed an increase in the availability of mouse Flt3L to human cells and a dose-dependent production of human IL-6 upon activation. Upon transplantation with low number of human HSPCs from adult bone marrow, these humanized mice demonstrated a significantly higher engraftment with multilineage differentiation of human lymphoid and myeloid cells, and tissue colonization at one year after adult HSPC transplant. Thus, these mice enable studies of human hematopoiesis and tissue colonization over time and may facilitate building autologous models for immuno-oncology studies.
用CD34造血干细胞和祖细胞(HSPCs)移植的人源化小鼠的临床前应用受到成年未动员HSPCs植入不足的限制。在此,我们基于NOD-SCID-(NSG)小鼠开发了一种新型免疫缺陷小鼠,以支持成年人类HSPCs的长期植入。由于Flt3L和IL-6在造血的许多方面都至关重要,我们敲除了小鼠基因并敲入了人类基因。由此产生的小鼠显示出小鼠Flt3L对人类细胞的可用性增加,并且在激活后会产生剂量依赖性的人类IL-6。在用来自成年骨髓的少量人类HSPCs进行移植后,这些人源化小鼠在成年HSPC移植后一年显示出人类淋巴细胞和髓细胞多谱系分化的显著更高植入率以及组织定植。因此,这些小鼠能够随着时间推移研究人类造血和组织定植,并可能有助于建立用于免疫肿瘤学研究的自体模型。